December 22, 2025
The U.S. behavioral health market is projected to expand from USD 101.84 billion in 2026 to USD 159.35 billion...
Read MoreDecember 26, 2025
The simulators market size is forecast to increase from USD 14.72 billion in 2026 to USD 25.53 billion by 2034...
Read MoreNovember 13, 2025
The hospital services market is predicted to grow from USD 13.19 trillion in 2026 to USD 28.99 trillion by 203...
Read MoreDecember 29, 2025
The cardiometabolic diseases market size is anticipated to grow from USD 292.04 billion in 2026 to USD 1987.69...
Read MoreJanuary 02, 2026
Projections indicate that, the global plasmid DNA manufacturing market will increase from USD 2.61 billion in 2025 to USD 14.59 billion by 2035, experiencing a CAGR of 18.77% over the next 10 years. Plasmid DNA is highly valuable in conducting research, studying diseases, studying gene mutations, repairing genetic material, and developing GMOs for ...
January 02, 2026
Projections indicate that, biosimilars industry is projected to rise from USD 40.87 billion in 2025 to USD 206.75 billion by 2035, reflecting a CAGR of 17.6% over the next decade. In 2024, key advancements in biosimilars were made: CuraTeQ Biologics' Hyderabad facility earned EMA GMP certification, ensuring global-quality production. Biocon Biologi...
December 31, 2025
Market insights predict, the sequencing industry is expected to grow from USD 23.28 billion in 2025 to USD 173 billion by 2035, driven by a CAGR of 22.21%. The market is witnessing rapid growth due to increased applications in different industries....
December 30, 2025
The next-generation metabolic therapies market is witnessing strong expansion and is expected to generate revenue in the hundreds of millions during the forecast period from 2026 to 2035, driven by rising cases of metabolic disorders such as obesity, diabetes, NAFLD/NASH, and cardiometabolic syndrome....
December 30, 2025
According to market projections, the RNA analysis sector is expected to grow from USD 6.86 billion in 2025 to USD 23.9 billion by 2035, reflecting a CAGR of 13.36%. The RNA analysis market is growing due to increasing demand for personalized medicine. North America is leading due to its advanced research infrastructure and favorable government envi...
December 30, 2025
Market insights predict, the carrier screening industry is expected to grow from USD 3.09 billion in 2025 to USD 18.58 billion by 2035, driven by a CAGR of 19.65%. An immense growth in prenatal screening programs and early detection is mainly influencing the global market expansion. Whereas, the presence of robust healthcare policies and syst...
December 30, 2025
Based on market forecasts, the DNA methylation sector will expand from USD 2.05 billion in 2025 to USD 7.36 billion by 2035, experiencing a CAGR of 13.64%. The emerging trend of genomic imprinting and gene expression regulation drives the importance of DNA methylation. North America dominated the market in 2024 owing to the robust research and deve...
December 30, 2025
Market insights predict the global cell harvesting industry will increase from USD 6.71 billion in 2025 to USD 22.68 billion by 2035, achieving a CAGR of 12.95%. The cell harvesting market is expanding due to rising demand for cell and gene therapies as well as growing use of stem cell-based treatment approaches. North America led the market due to...
December 30, 2025
According to market projections, the global biostimulants market, valued at USD 3.06 billion in 2024, is anticipated to reach USD 6.26 billion by 2034, growing at a CAGR of 7.44% over the next decade. Biostimulants are eco-friendly tools that boost plant growth, yield, and stress resistance. In 2024, Europe led the market, while Asia Pacific is set...
December 30, 2025
According to market projections, the microRNA market will increase from $2.05 billion in 2025 to $6.89 billion by 2035, including the dominant market share held by North America at 41.6% in 2025 and the rapidly expanding Asia Pacific region, which is expected to grow at the fastest rate during the forecast period....
+1 804 441 9344
+61 4859 81310 or +91 87933 22019
sales@towardshealthcare.com